NLRP3 and necrotizing enterocolitis: NLRP3 was found to be considerably activated in the intestinal tissue of NEC patients, and decreasing NLRP3 activity reduced intestinal inflammation and increased survival, as shown in an animal model of NEC [27, 28, 29].